EUVIMEDEUVIMED entdecken
Crossref

Antiarrhythmic Drug Use in the Blanking Period After Re‐Ablation and Recurrence in Paroxysmal Atrial Fibrillation

Haoming You, Sitong Li, Xueyuan Guo, Chao Jiang iD, Lu Zhou iD, Liu He, Wei Wang, Songnan Li, Ribo Tang iD, Nian Liu, Chenxi Jiang, Ronghui Yu und 6 weitere

Pacing and Clinical Electrophysiology · 2025

DOI: 10.1111/pace.15181 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pacing and Clinical Electrophysiology, 2025. Verfasst von Haoming You und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, National Clinical Research Centre for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Catheter Ablation, Anti-Arrhythmia Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Beijing Hospitals Authority Yangfan Program, National Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The effectiveness of continuous anti‐arrhythmic drugs (AAD) therapy during the 3‐month blanking period following repeat catheter ablation to prevent atrial fibrillation (AF) recurrence remains unclear. To evaluate the impact of continuous AAD therapy during the blanking period on AF recurrence in patients with paroxysmal atrial fibrillation (PAF) undergoing repeat ablation.

Methods

Patients with PAF who underwent repeat ablation from the China‐AF Registry (2011–2022) were included in this study and categorized into two groups based on AAD use during the 3‐month blanking period. The AF recurrence was defined as recurrent atrial tachyarrhythmias lasting for >30 s following the blanking period. Cox proportional hazard models were performed to assess the association between AAD status in the blanking period and AF recurrence at 12 months.

Results

The study included 740 PAF patients (mean age 59.4 ± 10.6 years, 36.1% female) who underwent repeat ablation, with 289 patients in the on‐AAD group and 451 in the off‐AAD group. At 12 months post‐ablation, 258 patients (34.9%) experienced AF recurrence. After adjusting for confounders, AAD use during the blanking period did not significantly associate with AF recurrence within 12 months after this period (HR = 1.07; 95% CI: 0.83–1.37; p = 0.599). Consistent results were found in different age, sex, body mass index, left atrial diameter, and CHA 2 DS 2 ‐VASc score subgroups.

Conclusions

There was no significant relationship between AAD therapy during the blanking period after repeat ablation and AF recurrence at 12 months in patients with PAF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationCatheter AblationAnti-Arrhythmia AgentsHumansMaleFemaleMiddle AgedRecurrenceRegistriesReoperation

Stichwörter der Autor:innen

antiarrhythmic drugatrial fibrillationblanking periodrecurrencerepeat catheter ablation

Substanzen

Anti-Arrhythmia Agents

Autor:innen und Institutionen

  • Department of Cardiology, National Clinical Research Centre for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing Advanced Innovation Center for Big Data-Based Precision Medicine for…
  • Heart Health Research Center (HHRC), Beijing, China.
  • The George Institute for Global Health, The University of New South Wales, Sydney, Australia.
  • Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

ORCID-Profile: Chao Jiang, Lu Zhou, Ribo Tang, Deyong Long, Changsheng Ma, Jianzeng Dong

Förderung

  • National Key Research and Development Program of China
  • Beijing Hospitals Authority Yangfan Program
  • National Science Foundation of China
  • National Natural Science Foundation of China

Zitieren

APA

You, H., Li, S., Guo, X., Jiang, C., Zhou, L., He, L., Wang, W., Li, S., Tang, R., Liu, N., Jiang, C., Yu, R., Zhou, N., Sang, C., Long, D., Du, X., Ma, C., & Dong, J. (2025). Antiarrhythmic Drug Use in the Blanking Period After Re‐Ablation and Recurrence in Paroxysmal Atrial Fibrillation. Pacing and Clinical Electrophysiology. https://doi.org/10.1111/pace.15181

Vancouver

You H, Li S, Guo X, Jiang C, Zhou L, He L, et al. Antiarrhythmic Drug Use in the Blanking Period After Re‐Ablation and Recurrence in Paroxysmal Atrial Fibrillation. Pacing and Clinical Electrophysiology. 2025. doi:10.1111/pace.15181

BibTeX
@article{You2025,
  author = {You, Haoming and Li, Sitong and Guo, Xueyuan and Jiang, Chao and Zhou, Lu and He, Liu and Wang, Wei and Li, Songnan and Tang, Ribo and Liu, Nian and Jiang, Chenxi and Yu, Ronghui and Zhou, Ning and Sang, Caihua and Long, Deyong and Du, Xin and Ma, Changsheng and Dong, Jianzeng},
  title = {Antiarrhythmic Drug Use in the Blanking Period After Re‐Ablation and Recurrence in Paroxysmal Atrial Fibrillation},
  journal = {Pacing and Clinical Electrophysiology},
  year = {2025},
  doi = {10.1111/pace.15181}
}
Kostenlos starten →